Work

Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy

Year: 2022

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-21-1044

Authors: Milad Soleimani, Alexander Somma, Tamer Kaoud, Ria Goyal, Jorge Bustamante, Dennis C. Wylie, Nisha Holay, Agnieszka Looney, Uma Giri, Todd Triplett, Kevin Dalby, Jeanne Kowalski, S. Gail Eckhardt, Carla Van Den Berg

Institution: The University of Texas at Austin

Language: English

Topic: Autophagy in Disease and Therapy

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Prevention and Research Institute of Texas, Dell Medical School, University of Texas at Austin

Awards: Targeted Therapeutic Drug Discovery & Development Program, Recruitment of Established Investigators

OpenAlex ID: W4292264843

FWCI: 2.441

Cites: 51

Cited by: 18

Related to: 10